4.7 Article

Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease

Journal

CELL STEM CELL
Volume 26, Issue 6, Pages 862-+

Publisher

CELL PRESS
DOI: 10.1016/j.stem.2020.05.004

Keywords

-

Funding

  1. European Research Council [ERCAdG 323182 STEMCARDIOVASC]
  2. European Community's Seventh Framework Programme (FP7/2007-2013) [602423]
  3. European Union's Horizon 2020 Research and Innovation Programme [668724]
  4. Netherlands Organ-on-Chip Initiative, an NWO Gravitation - Ministry of Education, Culture and Science of the government of the Netherlands [024.003.001]
  5. Transnational Research Project on Cardiovascular Diseases [JTC2016_FP-40-021 ACM-HF]
  6. Netherlands Organisation for Health Research and Development ZonMW (MKMD project) [114022504]
  7. Health-Holland TKI-LSH PPP-allowance [LSHM17013-H007]
  8. European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska Curie grant [707404]
  9. H2020 Societal Challenges Programme [668724] Funding Source: H2020 Societal Challenges Programme

Ask authors/readers for more resources

Cardiomyocytes (CMs) from human induced pluripotent stem cells (hiPSCs) are functionally immature, but this is improved by incorporation into engineered tissues or forced contraction. Here, we showed that tricellular combinations of hiPSC-derived CMs, cardiac fibroblasts (CFs), and cardiac endothelial cells also enhance maturation in easily constructed, scaffold-free, three-dimensional microtissues (MTs). hiPSC-CMs in MTs with CFs showed improved sarcomeric structures with T-tubules, enhanced contractility, and mitochondrial respiration and were electrophysiologically more mature than MTs without CFs. Interactions mediating maturation included coupling between hiPSC-CMs and CFs through connexin 43 (CX43) gap junctions and increased intracellular cyclic AMP (cAMP). Scaled production of thousands of hiPSC-MTs was highly reproducible across lines and differentiated cell batches. MTs containing healthy-control hiPSC-CMs but hiPSC-CFs from patients with arrhythmogenic cardiomyopathy strikingly recapitulated features of the disease. Our MT model is thus a simple and versatile platform for modeling multicellular cardiac diseases that will facilitate industry and academic engagement in high-throughput molecular screening.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available